| mRNA |
paclitaxel |
CCLE |
pan-cancer |
AAC |
-0.24 |
4e-07 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
4e-06 |
| mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-05 |
| mRNA |
BRD-K92856060 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-05 |
| mRNA |
17-AAG |
CCLE |
pan-cancer |
AAC |
-0.21 |
3e-05 |
| mRNA |
BRD-K26531177 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-05 |
| mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
| mRNA |
BRD-K16147474 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.0002 |
| mRNA |
ML210 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
| mRNA |
staurosporine |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
0.0007 |